Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Dynavax Technologies

NASDAQ DVAX
$11.04 0.04 0.36%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 25 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

1.44B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
1.51B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.32
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
130.20M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-21.03 %

Upcoming events Dynavax Technologies

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Dynavax Technologies

Stock analysis Dynavax Technologies

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
155.87 28.42
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.
2.31 4.33
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
-96.37 9.95
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
-4.89 0.65
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
1.49 7.67

Price change Dynavax Technologies per year

3.58$ 20.96$
Min Max

Summary analysis Dynavax Technologies

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Dynavax Technologies

Revenue and net income Dynavax Technologies

All parameters

Stock news Dynavax Technologies

All news
13 May 2022 в 17:35

Dynavax Technologies Shares Rise 22% on Addition to SmallCap 600

13 May 2022 в 17:31

Dynavax Technologies Shares Rise 22% on Addition to SmallCap 600

13 May 2022 в 00:46

Independence Realty Trust to Join S&P MidCap 400; Alpha & Omega Semiconductor & Dynavax Technologies to Join S&P SmallCap 600

13 May 2022 в 00:46

Independence Realty Trust to Join S&P MidCap 400; Alpha & Omega Semiconductor & Dynavax Technologies to Join S&P SmallCap 600

22 September 2021 в 21:00

Dynavax Technologies Shares Leap 31% After Clover Covid-19 Vaccine Data

22 September 2021 в 20:55

Dynavax Technologies Shares Leap 31% After Clover Covid-19 Vaccine Data

22 September 2021 в 15:25

Dynavax Technologies Shares Up After Clover Covid-19 Trial Data

22 September 2021 в 15:25

Dynavax Technologies Shares Up After Clover Covid-19 Trial Data

About company Dynavax Technologies

Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd.; and sublicense agreement with Merck, Sharp & Dohme Corp. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.
Address:
2100 Powell Street, EmeryVille, CA, United States, 94608
Company name: Dynavax Technologies
Issuer ticker: DVAX
ISIN: US2681582019
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2004-02-19
Sector: Healthcare
Industry: Biotechnology
Site: https://www.dynavax.com

On which stock exchange are Dynavax Technologies (DVAX) stocks traded?

Dynavax Technologies (DVAX) stocks are traded on NASDAQ.

What is the ticker of Dynavax Technologies stocks (DVAX)?

The stock ticker of Dynavax Technologies’s stocks or in other words, the code is DVAX. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Dynavax Technologies (DVAX) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Dynavax Technologies (DVAX) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Dynavax Technologies (DVAX) stocks traded?

Dynavax Technologies (DVAX) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Dynavax Technologies (DVAX) stocks today?

The current price of Dynavax Technologies stocks on 16.05.2024 is 11.04 dollars. per share.

What is the dynamics of Dynavax Technologies (DVAX) stocks from the beginning of the year?

Dynavax Technologies (DVAX) quotes have increased by -23.23% from the beginning of the year up to 11.04 dollars. per 1 stocks.

How much did Dynavax Technologies (DVAX) stocks increase in мае 2024?

This month Dynavax Technologies (DVAX) quotes have increased by -5.48% to 11.04 dollars. per share.

How much are Dynavax Technologies (DVAX) stocks worth?

Today, on October, 16.05.2024 Dynavax Technologies’s (DVAX) stocks cost 11.04 dollars..

What is the market capitalization of Dynavax Technologies (DVAX)?

Capitalization is the market value of Dynavax Technologies (DVAX) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 16.05.2024, the market capitalization of Dynavax Technologies (DVAX) is estimated at about 1437407989 dollars.